On the role of four small hairpins in the HIV-1 RNA genome

RNA Biology

Volumn 10, Issue 4, 2013, Pages 540-552

  Knoepfel, Stefanie A ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Hairpin; HIV 1; RNA; RNA structure; SHAPE

Indexed keywords

VIRUS RNA;

ARTICLE; GENE STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHYLOGENY; RNA CONFORMATION; RNA STRUCTURE; STRUCTURE ANALYSIS; VIRUS GENOME; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84879018021     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.24133     Document Type: Article

References (65)

1. Merino EJ, Wilkinson KA, Coughlan JL, Weeks KM. RNA structure analysis at single nucleotide resolution by selective 2′-hydroxyl acylation and primer extension (SHAPE). J Am Chem Soc 2005; 127:4223-31; PMID:15783204; http://dx.doi.org/10.1021/ja043822v.
2. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW Jr., Swanstrom R, et al. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 2009; 460:711-6; PMID:19661910; http://dx.doi.org/10.1038/nature08237.
3. Mortimer SA, Weeks KM. A fast-acting reagent for accurate analysis of RNA secondary and tertiary structure by SHAPE chemistry. J Am Chem Soc 2007; 129:4144-5; PMID:17367143; http://dx.doi.org/10.1021/ja0704028.
4. Vasa SM, Guex N, Wilkinson KA, Weeks KM, Giddings MC. ShapeFinder: a software system for high-throughput quantitative analysis of nucleic acid reactivity information resolved by capillary electrophoresis. RNA 2008; 14:1979-90; PMID:18772246; http://dx.doi.org/10.1261/rna.1166808.
5. Wilkinson KA, Merino EJ, Weeks KM. Selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE): quantitative RNA structure analysis at single nucleotide resolution. Nat Protoc 2006; 1:1610-6; PMID:17406453; http://dx.doi.org/10.1038/nprot.2006.249.
6. Simmonds P, Tuplin A, Evans DJ. Detection of genome-scale ordered RNA structure (GORS) in genomes of positive-stranded RNA viruses: Implications for virus evolution and host persistence. RNA 2004; 10:1337-51; PMID:15273323; http://dx.doi.org/10.1261/rna.7640104.
7. Davis M, Sagan SM, Pezacki JP, Evans DJ, Simmonds P. Bioinformatic and physical characterizations of genome-scale ordered RNA structure in mammalian RNA viruses. J Virol 2008; 82:11824-36; PMID:18799591; http://dx.doi.org/10. 1128/JVI.01078-08.
8. von Eije KJ, Berkhout B. RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside. Antivir Chem Chemother 2009; 19:221-33; PMID:19641231.
9. Knoepfel SA, Centlivre M, Liu YP, Boutimah F, Berkhout B. Selection of RNAi-based inhibitors for anti-HIV gene therapy. World Journal of Virology 2012; 1:79-90; http://dx.doi.org/10.5501/wjv.v1.i3.79.
10. Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005; 33:796-804; PMID:15687388; http://dx.doi.org/10.1093/nar/ gki220.
11. Westerhout EM, Berkhout B. A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res 2007; 35:4322-30; PMID:17576691; http://dx.doi.org/10.1093/nar/gkm437.
12. Low JT, Knoepfel SA, Watts JM, ter Brake O, Berkhout B, Weeks KM. SHAPE-directed discovery of potent shRNA inhibitors of HIV-1. Mol Ther 2012; 20:820-8; PMID:22314289; http://dx.doi.org/10.1038/mt.2011.299.
13. Aboul-ela F, Karn J, Varani G. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J Mol Biol 1995; 253:313-32; PMID:7563092; http://dx.doi.org/10. 1006/jmbi.1995.0555.
14. Aboul-ela F, Karn J, Varani G. Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res 1996; 24:3974-81; PMID:8918800; http://dx.doi.org/10.1093/nar/24.20. 3974.
15. Berkhout B. Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis. Nucleic Acids Res 1992; 20:27-31; PMID:1738599; http://dx.doi.org/10.1093/nar/20.1.27.
16. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, et al. Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA 1989; 86:6925-9; PMID:2476805; http://dx.doi.org/10.1073/pnas.86.18.6925.
17. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989; 338:254-7; PMID:2784194; http://dx.doi.org/10.1038/338254a0.
18. Jacks T, Power MD, Masiarz FR, Luciw PA, Barr PJ, Varmus HE. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 1988; 331:280-3; PMID:2447506; http://dx.doi.org/10.1038/331280a0.
19. Wilson W, Braddock M, Adams SE, Rathjen PD, Kingsman SM, Kingsman AJ. HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems. Cell 1988; 55:1159-69; PMID:3060262; http://dx.doi.org/10.1016/0092-8674(88)90260-7.
20. Klasens BIF, Thiesen M, Virtanen A, Berkhout B. The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res 1999; 27:446-54; PMID:9862964; http://dx.doi.org/ 10.1093/nar/27.2.446.
21. Abbink TE, Berkhout B. RNA structure modulates splicing efficiency at the HIV-1 major splice donor. J Virol 2007; 82:3090-8; PMID:18160437; http://dx.doi.org/10.1128/JVI.01479-07.
22. Aldovini A, Young RA. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J Virol 1990; 64:1920-6; PMID:2109098.
23. Baudin F, Marquet R, Isel C, Darlix JL, Ehresmann B, Ehresmann C. Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains. J Mol Biol 1993; 229:382-97; PMID:8429553; http://dx.doi.org/10.1006/jmbi.1993.1041.
24. Clavel F, Orenstein JM. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J Virol 1990; 64:5230-4; PMID:2204725.
25. Harrison GP, Lever AML. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J Virol 1992; 66:4144-53; PMID:1602537.
26. Laughrea M, Jetté L. A 19-nucleotide sequence upstream of the 5′ major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. Biochemistry 1994; 33:13464-74; PMID:7947755; http://dx.doi.org/10.1021/bi00249a035.
27. Lever A, Gottlinger H, Haseltine W, Sodroski J. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol 1989; 63:4085-7; PMID:2760989.
28. O'Reilly MM, McNally MT, Beemon KL. Two strong 5′ splice sites and competing, suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 1995; 213:373-85; PMID:7491762; http://dx.doi.org/10.1006/viro.1995.0010.
29. Purcell DFJ, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 1993; 67:6365-78; PMID:8411338.
30. Heng X, Kharytonchyk S, Garcia EL, Lu K, Divakaruni SS, LaCotti C, et al. Identification of a minimal region of the HIV-1 5′-leader required for RNA dimerization, NC binding, and packaging. J Mol Biol 2012; 417:224-39; PMID:22306406; http://dx.doi.org/10.1016/j.jmb.2012.01.033.
31. Sakuragi J, Ode H, Sakuragi S, Shioda T, Sato H. A proposal for a new HIV-1 DLS structural model. Nucleic Acids Res 2012; 40:5012-22; PMID:22328732; http://dx.doi.org/10.1093/nar/gks156.
32. Abbink TEM, Berkhout B. A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J Biol Chem 2003; 278:11601-11; PMID:12458192; http://dx.doi.org/10.1074/jbc. M210291200.
33. Ooms M, Abbink TE, Pham C, Berkhout B. Circularization of the HIV-1 RNA genome. Nucleic Acids Res 2007; 35:5253-61; PMID:17686788; http://dx.doi.org/10. 1093/nar/gkm564.
34. Lu K, Heng X, Garyu L, Monti S, Garcia EL, Kharytonchyk S, et al. NMR detection of structures in the HIV-1 5′-leader RNA that regulate genome packaging. Science 2011; 334:242-5; PMID:21998393; http://dx.doi.org/10.1126/ science.1210460.
35. Simon-Loriere E, Martin DP, Weeks KM, Negroni M. RNA structures facilitate recombination-mediated gene swapping in HIV-1. J Virol 2010; 84:12675-82; PMID:20881047; http://dx.doi.org/10.1128/JVI.01302-10.
36. Malim MH, Tiley LS, McCarn DF, Rusche JR, Hauber J, Cullen BR. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 1990; 60:675-83; PMID:2406030; http://dx.doi.org/10. 1016/0092-8674(90)90670-A.
37. Peleg O, Trifonov EN, Bolshoy A. Hidden messages in the nef gene of human immunodeficiency virus type 1 suggest a novel RNA secondary structure. Nucleic Acids Res 2003; 31:4192-200; PMID:12853637; http://dx.doi.org/10.1093/nar/ gkg454.
38. Berkhout B. Structure and function of the human immunodeficiency virus leader RNA. Prog Nucleic Acid Res Mol Biol 1996; 54:1-34; PMID:8768071; http://dx.doi.org/10.1016/S0079-6603(08)60359-1.
39. Kuiken C, Foley B, Leitner T, Apetrei C, Hahn B, Mizrachi I, et al. HIV Sequence Compendium 2010. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory. 2010.
40. Olivetta E, Pugliese K, Bona R, D'Aloja P, Ferrantelli F, Santarcangelo AC, et al. cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tails. J Virol 2000; 74:483-92; PMID:10590138; http://dx.doi.org/10.1128/JVI.74.1.483-492.2000.
41. Koken SEC, van Wamel JL, Goudsmit J, Berkhout B, Geelen JL. Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 1992; 191:968-72; PMID:1448931; http://dx.doi.org/10.1016/0042-6822(92)90274-S.
42. Beekwilder MJ, Nieuwenhuizen R, van Duin J. Secondary structure model for the last two domains of single-stranded RNA phage Q β. J Mol Biol 1995; 247:903-17; PMID:7723040; http://dx.doi.org/10.1006/jmbi.1995.0189.
43. Skripkin EA, Adhin MR, de Smit MH, van Duin J. Secondary structure of the central region of bacteriophage MS2 RNA. Conservation and biological significance. J Mol Biol 1990; 211:447-63; PMID:2407856; http://dx.doi.org/10. 1016/0022-2836(90)90364-R.
44. Berkhout B, van Duin J. Mechanism of translational coupling between coat protein and replicase genes of RNA bacteriophage MS2. Nucleic Acids Res 1985; 13:6955-67; PMID:3840590; http://dx.doi.org/10.1093/nar/13.19.6955.
45. Schmidt BF, Berkhout B, Overbeek GP, van Strien A, van Duin J. Determination of the RNA secondary structure that regulates lysis gene expression in bacteriophage MS2. J Mol Biol 1987; 195:505-16; PMID:3656423; http://dx.doi.org/10.1016/0022-2836(87)90179-3.
46. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101-5; PMID:16625202; http://dx.doi.org/10.1038/ nature04734.
47. Levy DE, García-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 2001; 12:143-56; PMID:11325598; http://dx.doi.org/10.1016/S1359-6101(00)00027-7.
48. Girardin SE, Sansonetti PJ, Philpott DJ. Intracellular vs extracellular recognition of pathogens - common concepts in mammals and flies. Trends Microbiol 2002; 10:193-9; PMID:11912027; http://dx.doi.org/10.1016/S0966- 842X(02)02334-X.
49. Saunders LR, Barber GN. The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J 2003; 17:961-83; PMID:12773480; http://dx.doi.org/10.1096/fj.02-0958rev.
50. Player MR, Torrence PF. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol Ther 1998; 78:55-113; PMID:9623881; http://dx.doi.org/10.1016/S0163-7258(97)00167-8.
51. Klase Z, Kale P, Winograd R, Gupta MV, Heydarian M, Berro R, et al. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol 2007; 8:63; PMID:17663774; http://dx.doi.org/10.1186/1471-2199-8-63.
52. Ouellet DL, Plante I, Landry P, Barat C, Janelle ME, Flamand L, et al. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 2008; 36:2353-65; PMID:18299284; http://dx.doi.org/10.1093/nar/gkn076.
53. Lefebvre G, Desfarges S, Uyttebroeck F, Muñoz M, Beerenwinkel N, Rougemont J, et al. Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J Virol 2011; 85:6205-11; PMID:21507965; http://dx.doi.org/10.1128/JVI.00252-11.
54. Schopman NC, Willemsen M, Liu YP, Bradley T, van Kampen A, Baas F, et al. Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res 2012; 40:414-27; PMID:21911362; http://dx.doi.org/10.1093/nar/gkr719.
55. Ding SW. RNA-based antiviral immunity. Nat Rev Immunol 2010; 10:632-44; PMID:20706278; http://dx.doi.org/10.1038/nri2824.
56. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev 2009; 227:75-86; PMID:19120477; http://dx.doi.org/10.1111/j.1600-065X.2008. 00737.x.
57. Berkhout B, van Hemert FJ. The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res 1994; 22:1705-11; PMID:8202375; http://dx.doi.org/10.1093/nar/22.9.1705.
58. van Hemert FJ, Berkhout B. The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availability. J Mol Evol 1995; 41:132-40; PMID:7666442.
59. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003; 31:3406-15; PMID:12824337; http://dx.doi.org/10.1093/nar/gkg595.
60. Das AT, Harwig A, Berkhout B. The HIV-1 Tat protein has a versatile role in activating viral transcription. J Virol 2011; 85:9506-16; PMID:21752913; http://dx.doi.org/10.1128/JVI.00650-11
61. van Montfort T, Thomas AA, Pollakis G, Paxton WA. Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans. J Virol 2008; 82:7886- 96; PMID:18524826; http://dx.doi.org/10.1128/JVI.00245-08.
62. Knoepfel SA, Abad A, Abad X, Fortes P, Berkhout B. Design of modified U1i molecules against HIV-1 RNA. Antiviral Res 2012; 94:208-16; PMID:22507247; http://dx.doi.org/10.1016/j.antiviral.2012.03.010.
63. Ruijter JM, et al. Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology. Retrovirology 2006; 3:1-8; PMID:16398928; http://dx.doi.org/10.1186/1742-4690-3-2.
64. Klaver B, Berkhout B. Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J 1994; 13:2650-9; PMID:8013464.
65. Beerens N, Berkhout B. The tRNA primer activation signal in the HIV-1 genome is important for initiation and processive elongation of reverse transcription. J Virol 2002; 76:2329-39; PMID:11836411; http://dx.doi.org/10. 1128/jvi.76.5.2329-2339.2002.